{
    "eid": "2-s2.0-84907420198",
    "title": "HIV multi-drug resistance at first-line antiretroviral failure and subsequent virological response in Asia",
    "cover-date": "2014-01-01",
    "subject-areas": [
        {
            "$": "Infectious Diseases",
            "@code": "2725"
        },
        {
            "$": "Public Health",
            "@code": "2739"
        }
    ],
    "keywords": [
        "Failure",
        "HIV",
        "Mutations",
        "Resistance",
        "Resource-limited"
    ],
    "authors": [
        "Awachana Jiamsakul"
    ],
    "citedby-count": 16,
    "ref-count": 42,
    "ref-list": [
        "Protease inhibitor therapy in resource-limited settings",
        "Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-saharan african countries: Implications for second-line ART strategies",
        "Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa",
        "HIV-1 virologic failure and acquired drug resistance among first-line antiretroviral experienced adults at a rural HIV clinic in coastal Kenya: A cross-sectional study",
        "Virological failure rates and HIV-1 drug resistance patterns in patients on first-line antiretroviral treatment in semirural and rural Gabon",
        "HIV-1 drug resistance at virological failure versus immunological failure among patients failing first-line antiretroviral therapy in a resource-limited setting",
        "HIV-1 drug resistance and associated factors among adults failing first-line highly active antiretroviral therapy in Ho Chi Minh City, Vietnam",
        "Trends in prevalence of HIV-1 drug resistance in Thailand 2009-2010",
        "Resistance-associated mutations in HIV-1 among patients failing first-line antiretroviral therapy",
        "Update of the drug resistance mutations in HIV-1: March 2013",
        "HIV-1 drug resistance mutations: An updated framework for the second decade of HAART",
        "Resistance-associated mutations after initial antiretroviral treatment failure in a large cohort of patients infected with HIV-1 Subtype CRF01_AE",
        "Multi-nucleoside reverse transcriptase inhibitor resistant HIV type-1 in a patient from Sierra Leone failing stavudine, lamivudine and nevirapine",
        "Accumulation of HIV drug resistance mutations in patients failing first-line antiretroviral treatment in South Africa",
        "Consolidated Guidelines on the Use of Antiretroviral Drugs for Treatment and Preventing HIV Infection [Internet]",
        "Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance-HIV drug resistance in sub-Saharan Africa and the Asia-Pacific",
        "TREAT Asia Quality Assessment Scheme (TAQAS) to standardize the outcome of HIV genotypic resistance testing in a group of Asian laboratories",
        "Capacity building and predictors of success for HIV-1 drug resistance testing in the Asia-Pacific region and Africa",
        "Web resources for HIV type 1 genotypic-resistance test interpretation",
        "An automated genotyping system for analysis of HIV-1 and other microbial sequences",
        "A standardized framework for accurate, high-throughput genotyping of recombinant and non-recombinant viral sequences",
        "Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over time",
        "HIV Testing, Treatment and Prevention: Generic Tools for Operational Research",
        "Genotypic susceptibility scores and HIV type 1 RNA responses in treatment-experienced subjects with HIV type 1 infection",
        "Comparative evaluation of seven resistance interpretation algorithms and their derived genotypic inhibitory quotients for the prediction of 48 week virological response to darunavir-based salvage regimens",
        "Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting",
        "AntiRetroScan 2.X [Internet]",
        "Index for rating diagnostic tests",
        "Low Primary and Secondary HIV Drug-Resistance after 12 Months of Antiretroviral Therapy in Human Immune-Deficiency Virus Type 1 (HIV-1)-Infected Individuals from Kigali, Rwanda",
        "Virological outcome and patterns of HIV-1 drug resistance in patients with 36 months' antiretroviral therapy experience in Cameroon",
        "Increased Risk of Q151M and K65R Mutations in Patients Failing Stavudine-Containing First-Line Antiretroviral Therapy in Cambodia",
        "Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa",
        "Accumulation of drug resistance and loss of therapeutic options precede commonly used criteria for treatment failure in HIV-1 subtype-C-infected patients",
        "Developments in CD4 and viral load monitoring in resource-limited settings",
        "Prevalence and Mutation Patterns of HIV Drug Resistance from 2010 to 2011 among ART-Failure Individuals in the Yunnan Province, China",
        "Characterization of HIV-1 antiretroviral drug resistance after second-line treatment failure in Mali, a limited-resources setting",
        "Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-1infected patients",
        "Sustained Virological Response on Second-Line Antiretroviral Therapy following Virological Failure in HIV-Infected Patients in Rural South Africa",
        "Emergence of HIV drug resistance during first- and second-line antiretroviral therapy in resource-limited settings",
        "Second-line antiretroviral treatment successfully resuppresses drug-resistant hiv-1 after first-line failure: Prospective cohort in sub-saharan africa",
        "Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries",
        "Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents"
    ],
    "affiliation": [
        {
            "affiliation-city": "Sungai Buloh",
            "affilname": "Hospital Sungai Buloh",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Manila",
            "affilname": "Research Institute for Tropical Medicine",
            "affiliation-country": "Philippines"
        },
        {
            "affiliation-city": "Bali",
            "affilname": "Universitas Udayana",
            "affiliation-country": "Indonesia"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Thai Red Cross Agency",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Kensington",
            "affilname": "The Kirby Institute",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Faculty of Medicine Ramathibodi Hospital, Mahidol University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hong Kong",
            "affilname": "Queen Elizabeth Hospital Hong Kong",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Faculty of Medicine Siriraj Hospital, Mahidol University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Providence",
            "affilname": "The Warren Alpert Medical School",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Chiang Mai",
            "affilname": "Chiang Mai University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "amfAR - The Foundation for AIDS Research",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Kota Bharu",
            "affilname": "Hospital Raja Perempuan Zainab II",
            "affiliation-country": "Malaysia"
        }
    ],
    "funding": [
        "National Cancer Institute",
        "National Institute of Allergy and Infectious Diseases",
        "National Institutes of Health",
        "National Institute of Allergy and Infectious Diseases",
        "National Institute of Allergy and Infectious Diseases"
    ]
}